Exciting isn't it, page-7

Hi AB,
you posted that "The Dep Docetaxel trial has been telegraphed to be completed in the next few months (conference call with CEO - she confirmed this on the 17/6/2017)"
But how can they put a completion date when they are still recruiting (according to their website)? Unless they have actually met the recruitment numbers and are just biding their time until BV is up and running. This is ethically possible if they are still preparing for ph 2 (and ph 3?) because progress in testing the drug is not being delayed.
After so many months (years) of ph1 testing I do so want to know how the initial group of patients responded to the treatment, and if an MTD has been reached.

And Forestgump69,
you say that if ph 1 results are good then ph 2 and 3 should be easy. Do you really think so, and should SPL go it alone with ph 3? They have certainly accumulated a lot of experience running ph 3 trials with BV and rBV